NTRA Q4 2021 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

Q4 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$173M+54.0% YoY

Gross Profit

$79M45.6% margin

Operating Income

-$140M-80.7% margin

Net Income

-$141M-81.2% margin

EPS (Diluted)

$-1.52

QoQ Revenue Growth

+9.4%

Cash Flow

Operating Cash Flow

-$99M

Free Cash Flow

-$108M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$583M

Stockholders' Equity

$653M

Cash & Equivalents

$84M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$173M	$112M	+54.0%
Gross Profit	$79M	$52M	+50.3%
Operating Income	-$140M	-$74M	-88.8%
Net Income	-$141M	-$76M	-84.0%

Revenue Segments

Product

$161M93%

Licensing and other

$12M7%

Geographic Segments

United States

$163M98%

Asia Pacific and Other

$3M2%

Americas, excluding U.S.

$995,0001%